<?xml version="1.0" encoding="iso-8859-1" ?>
<newsitem itemid="155677" id="root" date="1996-10-31" xml:lang="en">
<title>USA: Shaman Pharmaceuticals Q3 loss.</title>
<headline>Shaman Pharmaceuticals Q3 loss.</headline>
<dateline>SOUTH SAN FRANCISCO, Calif. 1996-10-31</dateline>
<text>
<p>SHAMAN PHARMACEUTICALS INC.</p>
<p>			  STATEMENT OF OPERATIONS</p>
<p>(in thousands, except per share amounts)(unaudited)</p>
<p>		    Three Months Ended  Nine Months Ended</p>
<p>			   Sept. 30,		  Sept. 30,</p>
<p>			  1996	  1995	 1996	   1995</p>
<p>				     (Note 2)		    (Note 2)</p>
<p>Revenue from</p>
<p>collaborative</p>
<p>  agreements	$   531   $     500   $  1,531    $   1,710</p>
<p>Operating expenses:</p>
<p>Research and development</p>
<p>			  4,754	 4,274     14,225	 12,570</p>
<p>General and</p>
<p>   administrative     862	   891	2,635	  2,760</p>
<p>Total operating</p>
<p>     expenses	 5,616	 5,165     16,860	 15,330</p>
<p>Loss from operations</p>
<p>			(5,085)     (4,665)   (15,329)     (13,620)</p>
<p>Other income (expense):</p>
<p>  Interest income     246	   425	  834	  1,304</p>
<p>  Interest expense  (146)	 (132)	(472)	  (419)</p>
<p> Net loss	   (4,985)     (4,372)   (14,967)     (12,735)</p>
<p>Net loss per share</p>
<p>			 (0.37)	(0.33)     (1.11)	 (0.97)</p>
<p>Shares used in the</p>
<p>calculation of</p>
<p>net loss per share</p>
<p>		   13,431,000  13,194,000  13,443,000  13,134,000</p>
<p>Note 1:  The balance sheet at Dec. 31, 1995 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. Note 2:  1995 operating expenses have been reclassified to conform to 1996 presentation.</p>
</text>
<copyright>(c) Reuters Limited 1996</copyright>
<metadata>
<codes class="bip:countries:1.0">
  <code code="USA">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1996-10-31"/>
  </code>
</codes>
<codes class="bip:industries:1.0">
  <code code="I25700">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1996-10-31"/>
  </code>
</codes>
<codes class="bip:topics:1.0">
  <code code="C15">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1996-10-31"/>
  </code>
  <code code="C151">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1996-10-31"/>
  </code>
  <code code="CCAT">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1996-10-31"/>
  </code>
</codes>
<dc element="dc.date.created" value="1996-10-31"/>
<dc element="dc.publisher" value="Reuters Holdings Plc"/>
<dc element="dc.date.published" value="1996-10-31"/>
<dc element="dc.source" value="Reuters"/>
<dc element="dc.creator.location" value="SOUTH SAN FRANCISCO, Calif."/>
<dc element="dc.creator.location.country.name" value="USA"/>
<dc element="dc.source" value="Reuters"/>
</metadata>
</newsitem>
